Roivant Sciences Finds Public Path via SPAC
Posted on 05/03/2021
Founded in 2014, Roivant Sciences is a biopharmaceutical and healthcare technology company. Montes Archimedes Acquisition Corp. (Nasdaq: MAAC) is a special purpose acquisition company sponsored by Patient Square Capital. Roivant Sciences is taking the SPAC route with Montes Archimedes Acquisition Corp. The transaction is expected to deliver up to US$ 611 million of gross proceeds […]
